Genotech Corporation (XKON:066830)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,099.00
+60.00 (5.77%)
At close: Mar 5, 2026
-21.39%
Market Cap 6.15B
Revenue (ttm) 7.28B
Net Income (ttm) -1.32B
Shares Out 5.60M
EPS (ttm) -280.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 428
Average Volume 2,063
Open 999.00
Previous Close 1,039.00
Day's Range 999.00 - 1,099.00
52-Week Range 805.00 - 1,601.00
Beta 0.18
RSI 55.53
Earnings Date n/a

About Genotech

Genotech Corporation provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally. The company offers standard, modified, dual labeled, and synthesis oligonucleotides; and gene synthesis services. It also provides sanger DNA sequencing services, which includes standard DNA, 16S/ITS, and insert clone sequencing, as well as primer walking; next generation sequencing; bioinformatics services; genomic services, such as SNP discovery/analysis and sequence finishing; and molecular diagn... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1997
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 066830
Full Company Profile

Financial Performance

In 2015, Genotech's revenue was 7.28 billion, an increase of 12.91% compared to the previous year's 6.45 billion. Losses were -1.32 billion, 250.7% more than in 2014.

Financial Statements

News

There is no news available yet.